ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CYBIN signs agreement to acquire Adelia Therapeutics pharmaceutical-business-review
December 10, 2020Cybin announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CDN$20,161,575 (approximately $15.75m) in an all-stock transaction.
Pharma Sources Insight January 2025
